NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

I believe NICE should also be aware that in due course (in it's forthcoming combination forms) DCVax will ultimately actually save the NHS money. Naysayers only look at the probable cover price of DCVax and compare it directly to existing drugs instead of whole treatment regimes thereby failing to take into account the vast additional costs associated with adjunctive/ supportive care from chemotherapy & radiation toxicity as well as immune-related adverse events (irAEs) from immunotherapies. ...

NICE certainly does take into account entire treatment costs, What you ignore is that -L is used in addition to the current SOC and all associated costs. And the patients will have similar side effects as SOC.

People can keep on talking about hype of future protocols, but what NICE will go by is actual studies protocol. That is surgery followed by chemo rad, Then chemo plus -L. So the costs will be completely additive,

All hypothetical of course.